Prep Shortages, Coverage Restrictions Create Colonoscopy Barriers Prep Shortages, Coverage Restrictions Create Colonoscopy Barriers
Patients are delaying or canceling colorectal cancer screenings because of prep-related hassles.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - February 18, 2022 Category: Cancer & Oncology Tags: Gastroenterology News Source Type: news

Post –COVID Vaccine AHA Cases Raise Eyebrows in Italy Post –COVID Vaccine AHA Cases Raise Eyebrows in Italy
"The overall number of cases observed does not allow...any definitive conclusion over a possible causal relationship between SARS-CoV-2 vaccination and AHA [acquired hemophilia A]."Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - February 18, 2022 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

5 Things to Know About PBMs 5 Things to Know About PBMs
Pharmacy benefit managers, who have come to dominate the prescription drug world in the US, use a range of ' abusive ' tactics to dictate how expensive oncology drugs are covered and paid for.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - February 18, 2022 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

FDA Approves First Drug for Rare Inherited Anemia FDA Approves First Drug for Rare Inherited Anemia
Mitapivat (Pyrukynd) is the first disease-modifying agent for hemolytic anemia in adults with pyruvate kinase (PK) deficiency.FDA Approvals (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - February 18, 2022 Category: Cancer & Oncology Tags: Hematology-Oncology News Alert Source Type: news

Gucs 2022 gucs 2022
Read clinically focused news coverage of key developments from GUCS 2022Medscape Oncology (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - February 18, 2022 Category: Cancer & Oncology Tags: Hematology-Oncology Conference Coverage Source Type: news

Eribulin Is Well Tolerated in Metastatic Breast Cancer Eribulin Is Well Tolerated in Metastatic Breast Cancer
However, the postmarketing study found two genetic polymorphisms that increase the risk of severe peripheral neuropathy. The study was published as a preprint and has not yet been peer reviewed.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - February 18, 2022 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Most Americans Unaware Alcohol Can Cause Cancer Most Americans Unaware Alcohol Can Cause Cancer
Increasing awareness of the alcohol –cancer link may help health advocates implement preventive alcohol policies in the US as drinking status, cancer awareness both help fuel policy support.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - February 17, 2022 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Breast Cancer Trials Enrolling Now: Could Your Patient Benefit? Breast Cancer Trials Enrolling Now: Could Your Patient Benefit?
Maybe one of your patients could benefit from clinical trials that are currently recruiting patients with breast cancer.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - February 16, 2022 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Brain Tumors Exact Higher Mortality Toll in Men Than Women Brain Tumors Exact Higher Mortality Toll in Men Than Women
Young adult men are more apt to develop brain tumors and die from the disease than women, and more research is needed to figure out why, researchers say.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - February 16, 2022 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Cost Not a Factor in RTx Type for Patients With Breast Cancer Cost Not a Factor in RTx Type for Patients With Breast Cancer
Physicians are increasingly opting for hypofractionated radiotherapy despite lower reimbursements rates for the procedure.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - February 16, 2022 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Virtual Exams for Routine Surveillance After Ovarian Cancer Virtual Exams for Routine Surveillance After Ovarian Cancer
Virtual visits may be a suitable alternative to the frequent in-person visits currently mandated for patients who are in remission from ovarian cancer.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - February 15, 2022 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Increase in Late-Stage Cancer Diagnoses After Pandemic Increase in Late-Stage Cancer Diagnoses After Pandemic
The scenario predicted by experts is now being reported; delays in cancer screening due to the pandemic have resulted in more late-stage presentations.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - February 15, 2022 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Shorter Courses of Chemo Treatment Taking Hold in Colon Cancer Shorter Courses of Chemo Treatment Taking Hold in Colon Cancer
In the wake of the pivotal IDEA trial, oncologists have shifted towards shorter adjuvant chemotherapy regimens for stage III colon cancer and a greater reliance on CAPOX instead of FOLFOX.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - February 15, 2022 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Medicaid Expansion Benefits Some CRC Patients, but Not Others Medicaid Expansion Benefits Some CRC Patients, but Not Others
Two new studies suggest the expansion of Medicaid under the Patient Protection and Affordable Care Act in 2010 may be leading to more frequent diagnosis of colorectal cancer (CRC) among Hispanics.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - February 15, 2022 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Vitiligo From Checkpoint Inhibitors Not Limited to Melanoma Vitiligo From Checkpoint Inhibitors Not Limited to Melanoma
Vitiligo can occur in any type of cancer, according to a new study published as a preprint and that has not yet peer reviewed.First Look (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - February 15, 2022 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news